E-LIB Suche - Ergebnisse für: Satybaldyeva, M.

1

Augmentation du risque thrombotique chez les patients SAPL ..:

Dufrost, V. ; Reshetnyak, T. ; Satybaldyeva, M....
JMV-Journal de Médecine Vasculaire. 44 (2019) 2 - p. 138 , 2019

Link: https://doi.org/10.1016/..

2

Effectiveness and safety of selective and non - selective f..:

Seredavkina, N V ; Reshetnyak, T M ; Satybaldyeva, M A...
Terapevticheskii arkhiv. 91 (2019) 5 - p. 19-25 , 2019

Link: https://doi.org/10.26442..

3

Chronic thromboembolic pulmonary hypertension developed in ..:

Movsisyan, G A ; Martynyuk, T V ; Mershin, K V...
Terapevticheskii arkhiv. 89 (2017) 9 - p. 93-99 , 2017

Link: https://doi.org/10.17116..

4

Effectiveness and safety of selective and non - selective f..:

N V Seredavkina ; T M Reshetnyak ; M A Satybaldyeva...
https://ter-arkhiv.ru/0040-3660/article/viewFile/33571/pdf. , 2019

Link: https://doi.org/10.26442..

5

Risk factors for venous thromboses in patients with rheumat..:

M. Satybaldyeva A ; T. Reshetnyak M ; N. Seredavkina V...
https://rsp.mediar-press.net/rsp/article/view/2643/1773. , 2019

Link: https://rsp.mediar-press..

6

Risk factors for venous thromboses in patients with rheumat..:

M. A. Satybaldyeva ; T. M. Reshetnyak ; N. V. Seredavkina..
https://rsp.mediar-press.net/rsp/article/view/2643. , 2019

Link: https://doi.org/10.14412..

7

VALIDATION OF A RUSSIAN-LANGUAGE VERSION OF THE VEINES-QOL/..:

M. Satybaldyeva A ; N. Seredavkina V ; S. Glukhova I...
https://rsp.mediar-press.net/rsp/article/view/2434/1619. , 2017

Link: https://rsp.mediar-press..

8

Chronic thromboembolic pulmonary hypertension developed in ..:

G A Movsisyan ; T V Martynyuk ; K V Mershin...
https://ter-arkhiv.ru/0040-3660/article/viewFile/32325/pdf. , 2017

Link: https://doi.org/10.17116..

9

VALIDATION OF A RUSSIAN-LANGUAGE VERSION OF THE VEINES-QOL/..:

M. A. Satybaldyeva ; N. V. Seredavkina ; S. I. Glukhova...
https://rsp.mediar-press.net/rsp/article/view/2434. , 2017

Link: https://doi.org/10.14412..

10

NEW ORAL ANTICOAGULANTS IN THE THERAPY OF ANTIPHOSPHOLIPID ..:

M. A. Satybaldyeva ; T. M. Reshetnyak
https://rsp.mediar-press.net/rsp/article/view/2221. , 2016

Link: https://doi.org/10.14412..

11

Risk factors for venous thromboembolic events in patients w..:

M. Satybaldyeva A ; T. Reshetnyak M ; N. Seredavkina V...
https://rsp.mediar-press.net/rsp/article/view/2267/1475. , 2016

Link: https://rsp.mediar-press..

12

Rheumatoid arthritis and venous thromboembolic events:

M. A. Satybaldyeva
https://rsp.mediar-press.net/rsp/article/view/2276. , 2016

Link: https://doi.org/10.14412..

13

NEW ORAL ANTICOAGULANTS IN THE THERAPY OF ANTIPHOSPHOLIPID ..:

M. Satybaldyeva A ; T. Reshetnyak M ; М. Сатыбалдыева А.
https://rsp.mediar-press.net/rsp/article/view/2221/1437. , 2016

Link: https://rsp.mediar-press..

14

Hydrogel composition based on carboxymethylcellulose and ag..:

Satybaldyeva, D. T. ; Mukhamedzhanova, M. Yu. ; Sarymsakov, A. A..
Chemistry of Natural Compounds. 34 (1998) 3 - p. 322-325 , 1998

Link: https://doi.org/10.1007/..

15

Risk factors for venous thromboembolic events in patients w..:

M. A. Satybaldyeva ; T. M. Reshetnyak ; N. V. Seredavkina...
https://rsp.mediar-press.net/rsp/article/view/2267. , 2016

Link: https://doi.org/10.14412..